Das Jai K, Kumar Rohail, Salam Rehana A, Freedman Stephen, Bhutta Zulfiqar A
BMC Public Health. 2013;13 Suppl 3(Suppl 3):S9. doi: 10.1186/1471-2458-13-S3-S9. Epub 2013 Sep 17.
Diarrheal diseases are the second leading cause of childhood morbidity and mortality in developing countries and an important cause of malnutrition. An estimated 0.75 million children below 5 years of age die from diarrhea. Vomiting associated with acute gastroenteritis (AGE) is a distressing symptom and limits the success of oral rehydration in AGE leading to an increased use of intravenous rehydration, prolonged emergency department stay and hospitalization. In this review we estimate the effect of antiemetics in gastroenteritis in children.
We conducted a systematic review of all the efficacy and effectiveness studies. We used a standardized abstraction and grading format and performed meta-analyses for all outcomes with more than two studies. The estimated effect of antiemetics was determined by applying the standard Child Health Epidemiology Reference Group (CHERG) rules.
We included seven studies in the review. Antiemetics significantly reduced the incidence of vomiting and hospitalization by 54%. Antiemetics also significantly reduced the intravenous fluid requirements by 60%, while it had a non-significant effect on the ORT tolerance and revisit rates.
Antiemetics are effective for the management of gastroenteritis in children and have the potential to decrease morbidity and mortality burden due to diarrhea, when introduced and scaled up.
腹泻病是发展中国家儿童发病和死亡的第二大主要原因,也是营养不良的一个重要原因。据估计,每年有75万5岁以下儿童死于腹泻。与急性胃肠炎(AGE)相关的呕吐是一种令人痛苦的症状,限制了AGE患儿口服补液的成功率,导致静脉补液的使用增加、急诊室停留时间延长和住院时间延长。在本综述中,我们评估了止吐药对儿童胃肠炎的疗效。
我们对所有疗效和有效性研究进行了系统综述。我们使用标准化的摘要和分级格式,并对两项以上研究的所有结局进行荟萃分析。止吐药的估计疗效是根据儿童健康流行病学参考组(CHERG)的标准规则确定的。
我们纳入了该综述中的七项研究。止吐药显著降低了呕吐发生率和住院率,降幅达54%。止吐药还显著降低了60%的静脉补液需求量,而对口服补液疗法(ORT)耐受性和复诊率无显著影响。
止吐药对儿童胃肠炎的治疗有效,在引入和扩大使用时,有可能减轻腹泻导致的发病和死亡负担。